We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

186 hedge funds and large institutions have $1.48B invested in Dr. Reddy's Laboratories in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 54 increasing their positions, 66 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

106% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 17

29% more capital invested

Capital invested by funds: $1.15B → $1.48B (+$337M)

10% more funds holding

Funds holding: 169186 (+17)

0.83% less ownership

Funds ownership: 65.08%64.24% (-0.83%)

18% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 66

18% less call options, than puts

Call options by funds: $1.84M | Put options by funds: $2.25M

Holders
186
Holders Change
+17
Holders Change %
+10.06%
% of All Funds
3.75%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
35
Increased
54
Reduced
66
Closed
17
Calls
$1.84M
Puts
$2.25M
Net Calls
-$410K
Net Calls Change
-$787K
Name Holding Trade Value Shares
Change
Change in
Stake
AAMU
51
Amundi Asset Management US
Massachusetts
$3.85M +$1.13M +95,075 +52%
DI
52
Dalton Investments
Nevada
$3.73M -$1.31M -110,000 -29%
SGA
53
Strategic Global Advisors
California
$3.67M +$2.03M +170,700 +183%
GH
54
GAM Holding
Switzerland
$3.41M +$474K +39,735 +19%
CAM
55
ClariVest Asset Management
California
$3.15M -$1.19M -100,000 -31%
Neuberger Berman Group
56
Neuberger Berman Group
New York
$2.73M +$1.76M +147,650 +301%
N
57
Natixis
France
$2.73M -$4.64M -389,110 -67%
Envestnet Asset Management
58
Envestnet Asset Management
Illinois
$2.73M +$1.24M +104,005 +113%
Legal & General Group
59
Legal & General Group
United Kingdom
$2.67M -$56.7K -4,760 -2%
CS
60
Credit Suisse
Switzerland
$2.34M -$162K -13,555 -7%
Geode Capital Management
61
Geode Capital Management
Massachusetts
$2.2M -$80.4K -6,750 -4%
PAM
62
Panagora Asset Management
Massachusetts
$2.17M
OSAM
63
O'Shaughnessy Asset Management
Connecticut
$2.16M +$367K +30,810 +25%
PHAM
64
Portland Hill Asset Management
United Kingdom
$1.77M +$18.2K +1,525 +1%
GT
65
Greenleaf Trust
Michigan
$1.75M +$14.6K +1,225 +1%
QI
66
Qtron Investments
Massachusetts
$1.74M -$886K -74,350 -37%
HJIM
67
Henry James International Management
New York
$1.68M -$13.6K -1,145 -0.9%
UCFA
68
United Capital Financial Advisors
Texas
$1.68M +$1.44M +120,725 New
Stifel Financial
69
Stifel Financial
Missouri
$1.67M -$12.3K -1,030 -0.8%
UBS Group
70
UBS Group
Switzerland
$1.64M -$189K -15,890 -12%
Voloridge Investment Management
71
Voloridge Investment Management
Florida
$1.52M -$1.43M -119,980 -52%
SFI
72
Susquehanna Fundamental Investments
Pennsylvania
$1.48M +$1.26M +106,010 New
NMC
73
Nine Masts Capital
Hong Kong
$1.46M +$1.23M +103,010 New
Nordea Investment Management
74
Nordea Investment Management
Sweden
$1.43M -$1.21M -101,935 -50%
ACI
75
AMP Capital Investors
Australia
$1.41M +$1.22M +102,510 New

RDY Hedge Fund Activity: Q3 2020 in Review

186 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2020, worth a combined $1.48B — up 29% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new RDY positions and 17 closed out — a net gain of 18 holders — while 54 added to existing stakes and 66 trimmed.

The largest buyer was Bank of Montreal, adding an estimated $10.9M. The largest seller was BlackRock, cutting an estimated $9.62M.

  • 186 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2020, up from 169 in Q2 2020.
  • Funds reported $1.48B of Dr. Reddy's Laboratories stock for Q3 2020, up 29% quarter-over-quarter.
  • 35 funds opened new Dr. Reddy's Laboratories positions in Q3 2020 and 17 closed out, a net change of +18 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q3 2020 was Bank of Montreal, an estimated $10.9M added.
  • The largest Dr. Reddy's Laboratories seller in Q3 2020 was BlackRock, an estimated $9.62M sold.

Based on aggregated 13F filings for Q3 2020.